Modest hypertension control in diabetic patients boosts survival
September 3, 2014|Hospitalist News (Archived)
Author and Disclosure Information
AT THE ESC CONGRESS 2014
The ADVANCE and ADVANCE-ON studies were partly funded by Servier. Dr. Chalmers has received research grants and honoraria from that company. Dr. Rydén has been an adviser to AstraZeneca, Roche, Bristol-Myers Squibb, and Sanofi, and received research grants from Roche.
On Twitter @mitchelzoler
